Drug-related visits to the emergency department

Journal of Pharmacy Practice

Volumn 18, Issue 5, 2005, Pages 329-335

  Zed, Peter J ^a,b,c  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b Faculty of Pharmaceutical Sciences   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adverse drug event; Drug related problem; Emergency department; Pharmaceutical care

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; AMOXICILLIN; ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIURETIC AGENT; HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PSYCHOTROPIC AGENT;

ASTHMA; BLEEDING; BONE MARROW SUPPRESSION; CARDIOVASCULAR DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DRUG ABUSE; DRUG ALCOHOL INTERACTION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INTOXICATION; DRUG MISUSE; DRUG OVERDOSE; ECONOMIC ASPECT; EMERGENCY TREATMENT; EMERGENCY WARD; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; MORBIDITY; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; PRESCRIPTION; PREVENTIVE MEDICINE; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; SELF MEDICATION; SKIN MANIFESTATION; STOMACH PAIN; TREATMENT FAILURE; TREATMENT REFUSAL;

EID: 33644800086     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190005280049     Document Type: Review

References (49)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-543.
2. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA. 1997;277:301-306.
3. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse events in hospitalized patients. JAMA. 1997;277:307-311.
4. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to the hospital. Pharmaceutical Journal. 2003;270:583-586.
5. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-1116.
6. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ. 2004;170:345-349.
7. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004;170:1678-1686.
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med. 1995;155:1949-1956.
9. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness Model. J Am Pharm Assoc. 2001;41:192-199.
10. Gandhi TJ, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.
11. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is this problem? Pharmacotherapy. 2002;22;915-923.
12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1206.
13. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic disease-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56:181-186.
14. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329;15-19.
15. Mcdonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331-1336.
16. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701-707.
17. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27:832-840.
18. Winterstein AG, Thomas EJ, Rosenberg EI, Hatton RG, Gozalez-Rothi R, Kanjanarat P. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health-Syst Pharm. 2004;61:1908-1916.
19. Prince BS, Goetz CM, Rihn TL, Olsk M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992;49:1696-1700.
20. Stoukides CA, D'Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm. 1993;50:712-714.
21. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health-Syst Pharm. 1996;53:1422-1426.
22. Schneitman-McIntire O, Farnen TA, Gordon N, Chan J, Toy WA. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health-Syst Pharm. 1996;53:1416-1422.
23. Smith KM, McAdams W, Frenia ML, Todd MW. Drug-related problems in emergency department patients. Am J Health-Syst Pharm. 1997;54:295-298.
24. Aparasu RR. Drug-related-injury visits to hospital emergency departments. Am J Health-Syst Pharm. 1998;55:1158-1161.
25. Aparasu RR, Helgeland DL. Visits to hospital outpatient departments in the United States due to adverse effects of medications. Hosp Pharm. 2000;35:825-831.
26. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug reactions in elderly patients presenting to the emergency department. Ann Emerg Med. 2001;38:666-671.
27. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975;234:1236-1241.
28. Hafner JW, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med. 2002;39:268-267.
29. Naranjo CA, Busto CA, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
30. Olshaker JS, Barish RA, Naradzay JF, Jerrard DA, Safir E, Campbell L. Prescription noncompliance: contribution to emergency department visits and cost. J Emerg Med. 1999;17:909-912.
31. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959-963.
32. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother. 1999;33:1252-1257.
33. Malhotra S, Karan RS, Pandhi P, Jain S. Drug-related medical emergencies in the elderly: role of adverse reaction and non-compliance. Postgrad Med J. 2001;77:703-707.
34. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.
35. Foppe Van Mil JW, Westerlund LT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859-867.
36. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795-801.
37. Lanski SL, Greenwald M, Perkins A, Simon HK. Herbal therapy use in a pediatric emergency department population: expect the unexpected. Pediatrics. 2003;111:981-985.
38. Rolniak S, Browning L, MacLeod BA, Cockley P. Complementary and alternative medicine use among urban ED patients: prevalence and patterns. J Emerg Nurs. 2004;30:318-324.
39. Li JZ, Quinn JV, McCulloch CE, Jacobs BP, Chan PV. Patterns of complementary and alternative medicine use in ED patients and its association with health care utilization. Am J Emerg Med. 2004;22:187-191.
40. Edwards GA, Samuels TM. The role of the pharmacist in emergency situations. Am J Hosp Pharm. 1968;25:128-133.
41. Elenbass RM, Waeckerle JF, McNabney WK. The clinical pharmacist in emergency medicine. Am J Hosp Pharm. 1977;34:843-846.
42. Whalen FJ. Cost justification of decentralized pharmaceutical services for the emergency room. Am J Hosp Pharm. 1981;38:684-687.
43. Troutman WG. The pharmacist in emergency medicine: poison information. Can J Hosp Pharm 1981;1:9-11.
44. Powell MF, Solomon DK, McEachen RA. Twenty-four hour emergency pharmaceutical services. Am J Hosp Pharm. 1985;42:831-835.
45. Berry NS, Folstad JE, Bauman JL, Leikin JB. Follow-up observations on 24-hour pharmacotherapy services in the emergency department. Ann Pharmacother. 1992;26:476-480.
46. Ammons DK, Roberts N. Prioritizing pharmacy services in the emergency department. Am J Health-Sys Pharm. 1997;54:1702-1705.
47. Serour S, Zelovics M, Trudel N, Manoukian C. Pharmacist needed in the ER, stat. Can J Hosp Pharm. 1999;52:387-392.
48. Vernon DD, Furnival RA, Hansen KW, et al. Effect of a pediatric trauma response team on emergency department treatment time and mortality of pediatric trauma victims. Pediatrics. 1999;103:20-24.
49. Fairbanks RJ, Hays DP, Webster DF, Spillane LL. Clinical pharmacy services in the emergency department. Am J Health-Sys Pharm. 2004;61:934-937.